Clinical trials
Gallbladder clinical trials
Below are recruiting gallbladder clinical trials, each written for real people, not researchers. We’re tracking 50 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04907643Recruiting
Virtual reality program to reduce stomach-cancer pain
This trial tests whether virtual reality (VR) can improve pain and other day-to-day symptoms in people with certain gastrointestinal cancers. You’d use VR for pain relief while researchers measure how you’re feeling.
Los Angeles, CaliforniaAges 18–99 - NCT06660576Recruiting
Gallbladder stones in children: causes and treatment
This trial studies gallbladder stones in children to understand what causes them. It looks at different types of stones and how they relate to conditions like hemolytic anemia, and helps guide treatment decisions.
SohagAges Up to 18 years - NCT07536191Recruiting
Gallbladder Drainage Methods for Acute Cholecystitis
This trial compares two ways to drain an inflamed gallbladder in patients who cannot safely have surgery: one approach goes through the stomach wall using ultrasound guidance, and the other goes through a bile duct opening. The goal is to find which method works better and causes fewer problems.
AichiAges 18 years+ - NCT07672145Recruiting
Gallbladder removal: belly button vs. upper belly cut
This trial compares two ways to remove the gallbladder during laparoscopic surgery: through the belly button or through a cut just below the breastbone. It aims to find which method causes less pain and recovers faster.
Lahore, Punjab ProvinceAges 18–60 - NCT05430035RecruitingEarly Phase 1
HIPEC for high-risk gallbladder cancer after surgery
This early-phase study tests whether a treatment called HIPEC is safe and feasible in people with high-risk gallbladder adenocarcinoma after surgery. HIPEC delivers chemotherapy directly into the abdomen during the operation to lower the chance of cancer coming back.
Morgantown, West VirginiaAges 18 years+ - NCT06591650RecruitingPhase 2
Combination therapy for advanced gallbladder cancer
This trial is testing a combination of four drugs (gemcitabine, cisplatin, nab-paclitaxel, and durvalumab) for people with gallbladder cancer that has spread or cannot be removed by surgery. The goal is to see if this drug combination helps shrink or control the cancer.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07321431Recruiting
Finding the best time to check gallbladder function
This study is looking for people with healthy gallbladders and bile ducts to find the best time to measure how well the gallbladder works. It uses a simple ultrasound test and does not involve any drugs or procedures.
Lanzhou, GansuAges 18–70 - NCT05285358RecruitingPhase 1
Aerosol chemo plus standard drugs for bile duct and gallbladder cancer
This trial tests a new way to give the drug paclitaxel directly into your belly as a mist, along with two standard chemo drugs given through your veins, for bile duct or gallbladder cancer that has spread to the lining of the belly. The goal is to see if this approach can better control the cancer in the belly.
Duarte, CaliforniaAges 18 years+ - NCT03637569Recruiting
Skinfold fat measurement and survival in certain digestive cancers
This study looks at whether a simple measurement of fat under the skin (taken at the back of the upper arm) relates to how long people live. It includes adults newly diagnosed with pancreatic, bile duct, or gallbladder cancer who are starting treatment.
SeoulAges 18 years+ - NCT04183712RecruitingPhase 2
Targeted drug treatment after gallbladder surgery using blood test monitoring
This Phase 2 trial tests a targeted treatment (GEMOX) given after gallbladder cancer surgery. It uses a blood test that looks for cancer-related DNA to monitor recurrence and guide care, aiming to improve outcomes for people with higher-risk disease.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT05184400Recruiting
Find new blood or tumor markers for bile duct and gallbladder cancer
This study looks for new ways to measure cancer-related “biomarkers” (signals in blood or tumor samples) in people with bile duct cancer or gallbladder cancer. The goal is to improve how these cancers are identified and tracked, which could help doctors make better treatment decisions.
Herlev, CopenhagenAges 18 years+ - NCT05404347Recruiting
Testing treatment response in gallbladder cancer patients
This trial studies how gallbladder cancer responds to treatment. It is for people newly diagnosed who have confirmed cancer in biopsy results.
Varanasi, Uttar PradeshAges 18–99 - NCT05757336RecruitingPhase 2
Study drug mix for unresectable gallbladder cancer
This Phase 2 trial tests a combination of cancer medicines (gemcitabine plus albumin-paclitaxel) along with immune therapy (sintilimab) and a blood-vessel–targeting drug (bevacizumab). It’s for people with gallbladder cancer that can’t be removed by surgery, to see if the treatment controls the cancer and improves outcomes.
ShanghaiAges 18–75 - NCT05833815RecruitingPhase 2/Phase 3
Everolimus added to standard care for gallbladder cancer
This trial tests whether adding everolimus to the usual treatment helps people with advanced (stage III inoperable or stage IV) gallbladder cancer live longer and control the disease better. You may be eligible if you have not had prior treatment for the advanced cancer, and your blood tests and organ functions are in safe ranges.
Varanasi, Uttar PradeshAges 18–99 - NCT07696546Recruiting
Gallbladder drainage: tube or scope?
This trial compares two minimally invasive ways to drain an infected gallbladder when you are too sick or not a candidate for surgery. It will help determine which approach works better and has fewer side effects.
Orlando, FloridaAges 18 years+ - NCT06967597Recruiting
Comparing watchful care vs. active treatment for gallbladder infection after stent placement
This trial looks at whether it is safe to delay treatment for a gallbladder infection in patients who have already had a special stent placed to drain the gallbladder. Patients who are too sick for surgery will be randomly assigned to receive either antibiotics with monitoring or immediate gallbladder removal.
Alicante, AlicanteAges 18 years+ - NCT07119203Recruiting
Robot vs standard keyhole gallbladder surgery for non-cancerous disease
This trial is comparing two types of keyhole surgery for removing the gallbladder: one done with a robot and the other with standard laparoscopic tools. The goal is to find out which technique leads to a better recovery and fewer complications for people with non-cancerous gallbladder problems like gallstones or polyps.
PortsmouthAges 18 years+ - NCT07146646RecruitingPhase 2
Chemo combo for advanced bile duct cancer
This trial tests a combination of two chemotherapy drugs (trifluridine/tipiracil and oxaliplatin) for people with advanced or metastatic bile duct cancer (including gallbladder cancer) who have only had one prior treatment. The goal is to see if this combination can help control the cancer.
Cleveland, OhioAges 19 years+ - NCT07222527Recruiting
One stent versus two for gallbladder problems
This trial tests whether using one plastic stent or two is better for people with gallbladder disease who need an ERCP but can't have gallbladder surgery right away. It aims to find which approach works best to keep the bile duct open and prevent complications.
Rochester, MinnesotaAges 18–95 - NCT02920554Recruiting
Surgery comparison for T2–T3 gallbladder cancer
This study looks at whether a specific type of liver surgery (removing tissue in a wedge shape versus a different liver resection) improves outcomes for some patients with T2 or T3 gallbladder cancer. It may help decide the best surgical approach after the gallbladder has already been removed.
SuwonAges 19–80 - NCT07452848Recruiting
Pringle maneuver's effect on gallbladder after liver surgery
This trial studies whether a technique called the Pringle maneuver (temporarily stopping blood flow to the liver during surgery) affects gallbladder health after liver surgery. It is for people having a liver tumor removed while keeping their gallbladder.
Hefei, AnhuiAges 18–85 - NCT07636824RecruitingPhase 2
Chemotherapy plus radiation after bile duct cancer surgery
This study tests whether combining chemotherapy and radiation therapy after surgery improves outcomes for patients with bile duct or gallbladder cancer. It's designed for patients whose surgery showed signs the cancer might come back.
BeijingAges 18–80 - NCT07310069Enrolling by invitationPhase 2
Testing a new drug combination for advanced gallbladder cancer
This trial tests a combination of two chemotherapy drugs (gemcitabine and nab-paclitaxel) with two immunotherapy drugs (iparomlimab and tuvorilimab) for people with advanced gallbladder cancer that cannot be removed by surgery. The goal is to see if this combination can help shrink the cancer or slow its growth.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06901622Enrolling by invitationPhase 2
Testing a combination of drugs for advanced gallbladder and bile duct cancer
This trial tests whether adding a targeted therapy (anlotinib) to standard chemo plus an immunotherapy (camrelizumab) is more effective than chemo plus immunotherapy alone for advanced gallbladder or bile duct cancers that cannot be removed by surgery.
ZhengzhouAges 18–75
Hear when a new Gallbladder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for gallbladder?
- Yes. Clin2 currently lists 50 recruiting gallbladder studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a gallbladder trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a gallbladder trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.